热景生物：参股公司获国内III类医疗器械注册证

Core Viewpoint - The announcement highlights that a significant associate company of the firm, Aorui Biotech, has recently obtained a Class III medical device registration certificate in China for a product that includes six gene methylation detection kits, enhancing the company's cancer detection product offerings [1] Group 1: Product Registration Details - The product is identified as TSPYL5 and five other gene methylation detection kits [1] - The registration certificate number is Guo Xie Zhu Ren 20253402195, issued on October 30, 2025, and valid until October 29, 2030 [1] - The issuing authority is the National Medical Products Administration of China [1] Group 2: Product Application and Market Impact - The product is intended for in vitro qualitative detection of related genes in human plasma, specifically for assisting in the diagnosis of suspected primary liver cancer [1] - The certification expands the company's range of tumor detection products and enhances its liver cancer detection product line [1] - However, the sales of the product may be influenced by multiple factors, leading to uncertainties [1]